Spyre Therapeutics Inc (SYRE)

Operating Income Growth

5.09%

TTM · Period ending:

SYRE logo

SYRE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported5.09%
SYRE TTM Operating Income YoY % (-27.08% → 5.09%)
High-resolution chart · PNG

SYRE operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Spyre Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
5.0941%
5.9354%
-0.4775%
-10.5658%
-35.8419%
20.9798%
13.9235%
10.3567%
27.6878%
-242.7476%
-185.7987%
-150.463%
-146.5428%
-10.107%
-29.1429%
-26.5919%
-33.1029%
10.8928%
19.4303%
15.6685%
22.2409%
1.2619%
-1.4278%
-9.3368%
-32.6038%
-48.882%
-76.7019%
-100.4404%
-96.1554%
-85.4574%
-64.2746%
-38.3273%
-30.705%
-25.0063%
-26.3353%
-30.609%
-42.4525%
-76.4706%
-93.6014%
-93.9232%
-70.9646%
-27.5485%
-27.0777%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.